Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mahlke

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Zentralblatt Fur Gynakologie|January 1, 1995
[Persistent granulocytosis and hyperuricemia after a single G-CSF injection (Filgrastim) in treatment of chemotherapy-induced myelosuppression in metastatic breast carcinoma]M Hofmann, M Mahlke, F Casper, et al.
Zentralblatt Fur Gynakologie|January 1, 1985
[Expanded possibilities of the treatment of vulvar cancer by plastic reconstructive procedures]P G Knapstein, M Mahlke, W Poleska, et al.
Der Gynakologe|December 1, 1988
[Reconstructive measures in radical vulva operations]P G Knapstein, M Mahlke, W Poleska, et al.
Archives of Gynecology and Obstetrics|January 1, 1989
[Surgical treatment of vulvar cancer and plastic reconstruction of vulvar defects]P G Knapstein, M Mahlke, W Poleska, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1996
[High dose chemotherapy in treatment of breast carcinoma: current status and limits of this method of therapy]H G Derigs, C Huber, M Mahlke, et al.
Oncology|January 1, 1985
Oral high-dose medroxyprogesterone acetate (MPA) treatment: cortisol/MPA serum profiles in relation to breast cancer regressionM Mahlke, H J Grill, P Knapstein, et al.
Geburtshilfe Und Frauenheilkunde|February 1, 1991
[Intra-arterial preoperative chemotherapy of advanced cervix cancer]P G Knapstein, R Kreienberg, T Beck, et al.
Journal of Cancer Research and Clinical Oncology|April 26, 2003
p53 expression and resistance against paclitaxel in patients with metastatic breast cancerM Schmidt, A Bachhuber, A Victor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trialE Heidemann, H Stoeger, R Souchon, et al.
British Journal of Cancer|January 11, 2007
Role of the progesterone receptor for paclitaxel resistance in primary breast cancerM Schmidt, E Bremer, D Hasenclever, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Zentralblatt Fur Gynakologie|January 1, 1995
[Persistent granulocytosis and hyperuricemia after a single G-CSF injection (Filgrastim) in treatment of chemotherapy-induced myelosuppression in metastatic breast carcinoma]M Hofmann, M Mahlke, F Casper, et al.
Zentralblatt Fur Gynakologie|January 1, 1985
[Expanded possibilities of the treatment of vulvar cancer by plastic reconstructive procedures]P G Knapstein, M Mahlke, W Poleska, et al.
Der Gynakologe|December 1, 1988
[Reconstructive measures in radical vulva operations]P G Knapstein, M Mahlke, W Poleska, et al.
Archives of Gynecology and Obstetrics|January 1, 1989
[Surgical treatment of vulvar cancer and plastic reconstruction of vulvar defects]P G Knapstein, M Mahlke, W Poleska, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1996
[High dose chemotherapy in treatment of breast carcinoma: current status and limits of this method of therapy]H G Derigs, C Huber, M Mahlke, et al.
Oncology|January 1, 1985
Oral high-dose medroxyprogesterone acetate (MPA) treatment: cortisol/MPA serum profiles in relation to breast cancer regressionM Mahlke, H J Grill, P Knapstein, et al.
Geburtshilfe Und Frauenheilkunde|February 1, 1991
[Intra-arterial preoperative chemotherapy of advanced cervix cancer]P G Knapstein, R Kreienberg, T Beck, et al.
Journal of Cancer Research and Clinical Oncology|April 26, 2003
p53 expression and resistance against paclitaxel in patients with metastatic breast cancerM Schmidt, A Bachhuber, A Victor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trialE Heidemann, H Stoeger, R Souchon, et al.
British Journal of Cancer|January 11, 2007
Role of the progesterone receptor for paclitaxel resistance in primary breast cancerM Schmidt, E Bremer, D Hasenclever, et al.
Pageof 2